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Background: Despite the existence of adequate technological infrastructure and clearer policies, there are situations where
users, mainly physicians, resist mobile health (mHealth) solutions. This is of particular concern, bearing in mind that several
studies, both in developed and developing countries, showed that clinicians’ adoption is the most influential factor in such
solutions’ success.
Objective: The aim of this study was to focus on understanding clinicians’ roles in the adoption of an oncology decision support
app, the factors impacting this adoption, and its implications for organizational and social practices.
Methods: A qualitative case study of a decision support app in oncology, called ONCOassist, was conducted. The data were
collected through 17 in-depth interviews with clinicians and nurses in the United Kingdom, Ireland, France, Italy, Spain, and
Portugal.
Results: This case demonstrates the affordances and constraints of mHealth technology at the workplace, its implications for
the organization of work, and clinicians’ role in its constant development and adoption. The research findings confirmed that
factors such as app operation and stability, ease of use, usefulness, cost, and portability play a major role in the adoption decision;
however, other social factors such as endorsement, neutrality of the content, attitude toward technology, existing workload, and
internal organizational politics are also reported as key determinants of clinicians’ adoption. Interoperability and cultural views
of mobile usage at work are the key workflow disadvantages, whereas higher efficiency and performance, sharpened practice,
and location flexibility are the main workflow advantages.
Conclusions: Several organizational implications emerged, suggesting the need for some actions such as fostering a work culture
that embraces new technologies and the creation of new digital roles for clinicians both on the hospitals or clinics and on the
development sides but also more collaboration between health care organizations and digital health providers to enable electronic
medical record integration and solving of any interoperability issues. From a theoretical perspective, we also suggest the addition
of a fourth step to Leonardi’s methodological guidance that accounts for user engagement; embedding the users in the continuous
design and development processes ensures the understanding of user-specific affordances that can then be made more obvious
to other users and increase the potential of such tools to go beyond their technological features and have a higher impact on
workflow and the organizing process.
(JMIR Mhealth Uhealth 2019;7(5):e13555)   doi:10.2196/13555
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Globally, health care sectors are facing persistent challenges
including increasing costs, inconsistent patient care, and a
growing burden of chronic disease. One way of overcoming
these challenges that have become increasingly the focus of
policy change is the transformation of care through a
patient-centric service design and taking a more proactive and
preventive approach that focuses on quality of life and not only
on treating the disease [1].
Smartphones can and do play a strong role here. The latest
developments in mobile technology have allowed smartphones
to achieve increasingly sophisticated tasks [2], so much so that
a new area of health, mobile health (mHealth), has emerged [3].
The global observatory of electronic health in the World Health
Organization defines mHealth as “medical and public health
practice supported by mobile devices, such as mobile phones,
patient monitoring devices, personal digital assistants (PDAs),
and other wireless devices” [4]. mHealth solutions differ from
other information and communication technology applications
in the sense that they are typically user-driven, accessible, and
affordable [5]; therefore, a good understanding of the factors
impacting user adoption and the roles they play in such adoption
are key to the success of such solutions.
However, despite the existence of adequate technological
infrastructure and clearer policies, there are situations where
users, mainly physicians, resist mHealth solutions [6]. This is
particularly relevant, bearing in mind that several studies, both
in developed and developing countries, showed that clinicians’
adoption is the most influential factor in such solutions’ success
[7-10]. Remarkably, studies show that social aspects are the
major factor behind the nonadoption of new technologies,
mainly owing to their complexity and the fact that users tend
to prefer existing systems over newly introduced ones [11,12].
Furthermore, clinicians’ attitude toward risk is a crucial element
in the successful implementation of new health care technologies
[13].
Objectives
Therefore, this research focuses on understanding clinicians’
roles in the adoption of mHealth solutions and its implications
for clinicians’ practice. The topic is investigated through the
following subquestions:
• What are clinicians’ roles in the adoption of mHealth
solutions?
• What are the factors that constrain or afford clinicians’
adoption of mHealth?
• Does the use of mHealth impact social practices in this
context? How?
These questions are addressed through a case study of an
oncology decision support mHealth solution called ONCOassist
and its adoption by clinicians across Europe.
Created in 2012, ONCOassist, shown in (Multimedia Appendix
1), is a free decision support app for oncology clinicians, with
over 11,000 active users worldwide in 2019 at the time of
writing this paper. The app gives oncologists and oncology
nurses easy access to a range of features that aim to help them
save time and improve the quality of patient care. The app’s
key features are explained in Multimedia Appendix 2.
User research, as a mode of inquiry, has shifted from the
assumption that there is a stable material thing (a technology)
and separate and identifiable user preferences in relation to it
toward an understanding in which use and technology are seen
as bound together within one another and are constitutive of
one another [14-16]. From this ontological perspective, it is
challenging to explain user choices within existing modes of
inquiry [17-20]. It follows that new and more balanced
user-research methodologies are needed if questions about user
choices and preferences, with regard to new technology, are to
be asked.
Contemporary sociomaterial scholars explain that, from their
perspective, the social and material combine over time
(imbricate) to yield stable sociomaterial constructions—such
as stable patterns of use and new organizational structures [21].
Technology partly constrains these constructions, without wholly
determining them, as users interact with certain preferred
features of technology to create particular technology
affordances [17,18,22,23]; that is to say that technology is
defined not just by its functions and its materiality but by how
precisely it is constructed through use. At the same time, use
cannot be seen as distinct from those functions or the materiality
of the technology in question [22]. Technology affordance, in
other words, lies somewhere between the user and technology.
Understanding the affordances resulting from this sociomaterial
interaction is also key in accounting for how technology impacts
on organizations and the process of organizing, as people’s
interactions with objects influences the way they organize their
microlevel relations [24] and also impacts on the definition of
people’s roles [25,26]. Moreover, as organizations become
increasingly digital, scholars have portrayed how the
technologies used at the workplace are central to the enablement
of new forms of organizing and practice and how, in turn, new
practices are essential to the enablement of new technologies
and new organizational forms [27,28].
Therefore, to better understand the role of clinicians (the users)
in the adoption of mHealth (new technologies) and the
implications for health care organizations (organizing), the
research themes and questions were developed in line with
Leonardi’s Methodological Guidelines for the Study of
Materiality and Affordances to crystallize the focus of the data
collected in the interviews [22].
This study used Leonardi’s guidance to build a solid analysis
of the role of users in technology adoption and its impact on
organizations following these 3 main steps:
• Understanding and documenting the material aspects of
technology and their limitations by identifying utility and
limitations of the app as perceived by the participating
clinicians.
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• Linking the material aspects of technology to the tasks that
they enable and facilitate by recognizing the real constraints
upon opportunities faced by clinicians when using the app.
• Recognizing the processes resulting from these affordances
and determining the consequential interactions taking place
in the organization by understanding the workflow
advantages and disadvantages related to the app’s usage.
The following section explains the research method and how
the interview questions and subsequently the analysis stemmed
from these 3 steps.
Methods
A qualitative paradigm was adopted because it gives precedence
to the voices of participants and the individual and unique
reflexivity of the researcher [29] and because of the rich insights
it offers, which can help draw out and understand clinicians’
experiences and perceptions in different ways that quantitative
methods cannot [30,31].
Data Collection
The data were collected via in-depth semistructured interviews.
Given that participants were in many different locations across
Europe, not all interviews were held face-to-face, some of them
were conducted via Skype, Google Hangouts, or telephone
conferencing. Furthermore, physical artifacts such as screenshots
of the app, the devices it can be used on, and example written
feedback to the developers (eg, app reviews on the app store)
were collected to develop a broader perspective about the
solution subject of the study [32]. The data collection took place
from February 2018 to January 2019, and a total of 17 interviews
were conducted with 13 participants (4 were follow-up
interviews with the same participants to clarify some details or
to ask more questions that were necessary for the analysis). The
interviews lasted between 23 min and 110 min and were all
conducted and recorded by the first author (CJ) in English. Data
collection stopped when an acceptable level of saturation was
reached.
Sampling Techniques and Participants’ Profiles
Purposive sampling was used, where potential participants were
selected based on their ability to provide rich and in-depth
information about the research topic [29,30]. Key informants
in the participating company were contacted, and a snowballing
sampling was used to identify suitable participants in their
solutions’ user base. The main selection criteria were that
participants must be active clinicians or former users of the app
being studied. To avoid the possible selection bias that might
result from the key informants selectively choosing users with
a positive inclination toward the studied solution, it was agreed
that participants would be asked if they can in turn refer to other
colleagues who were using the solution and were willing to
participate. Some participants did refer other colleagues, who
were using the app, and some agreed to participate in the study.
However, unfortunately, none of the users who had discontinued
use of the app agreed to take part in the research when they
were asked.
The participants were working in hospitals and clinics in the
United Kingdom, Ireland, France, Italy, Spain, and Portugal;
and the sample was composed of 8 oncologists (one of them
was also an ONCOassist cofounder), 3 nurses, and 2 other
members from the ONCOassist team as shown in Table 1.
Data Analysis and Ethical Considerations
Thematic analysis was used to identify and extract themes that
addressed the research questions and explained what each theme
could mean as well as the links between themes [33]. QSR’s
NVivo was used for coding and then excerpts were selected to
create an account that tells the narrative of each theme in a way
that helps the reader to understand the analysis. The first author
(CJ) conducted the interviews and did the initial analysis and
coding; she is a digital strategist with more than 17 years of
experience and has contributed to the creation and realization
of several digital solutions in health care. Then, the second
author (ASV) reviewed the coding; any cases of disagreement
about coding were discussed in conjunction with the last author
(CI) and mutually agreed. The thematic map is represented in
Multimedia Appendix 3, and the phases of the thematic analysis
are clarified in Multimedia Appendix 4.
Table 1. Sample demographics and characteristics (N=13).
CompositionSample Characteristics
Function (%)
61.58 oncologists (one of them is also an ONCOassist cofounder)
233 nurses




7.25Tech awareness (Participants were asked to define their tech awareness on a scale of 1 to 10), mean
14.5Health care experience (years), mean
7Mobile health experience (years), mean
United Kingdom, Ireland, France, Italy,
Spain, and Portugal
Location
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The infographic creator, Venngage, was used to visualize some
of the findings and not to quantify the data but to emphasize
the frequency by showing visually which themes were brought
up by more participants than others. The frequency reflected in
the infographics counts the theme only once per participant and
does not accumulate if the same participant brought up the same
theme several times. Such visualization mainly aims to improve
the comprehension of the article especially when contrasting 2
elements such as workflow advantages and disadvantages [34]
and can provide a clear and simple illustration of the dominant
themes and ideas for lay readers [35].
Ethical approval was obtained from the Faculty Research Ethics
Panel under the terms of Anglia Ruskin University’s Research
Ethics Policy, and all participants were briefed about the
research context and signed a study consent form agreeing to
participate.
Interview Themes and Questions
The interview questions addressing each of the 3 following
themes are reflected in the interview topic guides available in
Multimedia Appendix 5. The first interview guide was used for
clinicians and the second was used for providers.
Theme 1: Accounting for Materials
This theme evolves around understanding the limitations of
technology and the types of uses that it enables. Understanding
the material aspects of mHealth solutions is crucial because it
allows us to identify the different ways it can be used as well
as things that cannot be done with it owing to material
limitations.
According to Leonardi, technological features “can have various
degrees of utility based on the forms into which they are cast”
[22]. He explains that a good understanding of the technological
features of the solution, recognizing what it can do versus what
it cannot do, should help avoid the misconception that users can
achieve unlimited tasks with the technologies that they use in
their daily work. Therefore, understanding not only the
opportunities but also the limitations of mHealth solutions is
crucial as a first step of the analysis.
The way a technological tool is built matters because based on
that some uses might be very difficult or impossible to achieve,
the same way that materials often resist scientists’ efforts to
control them, implying that materials have agency [36].
Nevertheless, the user’s ability to rearrange or reshape the
materials impacts the way they are used [37].
Therefore, researchers need to understand the materials that
form a specific technological tool, how they are organized into
specific features, and what such features do or not do. Answering
these questions is key to understanding any potential limitations
to the use of a specific technology at work; therefore,
recognizing the real constraints upon opportunities is the first
step toward the rationalization of the role of materiality [22].
Theme 2: Accounting for Materiality
The focus of this theme is to understand users’ perceptions of
technology and how they intend to use it. Leonardi clarifies that
people’s views of technology can influence the way they utilize
it in their everyday practice; he explains that claiming that a
certain technology has materiality means that its materials are
being entangled or imbricated with users’ experiences and
culture in forms that make it hard to define the technological
tool separately from its context of usage [22]. This understanding
acknowledges that users’ intentions and the goals that they want
to achieve when using a specific technology have an impact on
its affordances.
Several scholars believe that materiality is mainly created
through observations of affordance and constraint [18,38,39];
such observations can explain how materiality arises at the
junction between technology and its users [40,41]. Some
scholars suggest that affordances happen when the existing
material properties of a specific technology are given a meaning
based on its users’ behavior and that people will not interact
with a technology unless they already recognize its utility [42];
this would entail that one technology can result in different
outcomes based on the understanding that materiality can offer
various affordances [22]. Conversely, other scholars suggest
that affordances are created by design and waiting to be
perceived, are not altered across the diverse contexts of use, and
are not created by the users but rather by the designers, and it
is up to the users to discover them [43,44].
Hutchby takes the middle ground explaining that affordances
go beyond users and technology’s properties and are established
based on the kind of relationship formed between people and
the technology that they use; accordingly, affordances of a
specific solution can change from one context to another even
when its material features remain unchanged [45]. This is
because users usually have different objectives when
approaching materiality, so they distinguish different uses that
a specific technology can afford [36]. This relational nature of
affordances also means that technology can have various uses,
which can result in various ways in how work is organized
[46,47].
Therefore, researchers need to understand what social
organizations shape the users’ objectives, how these objectives
impact users’ understandings of what a specific technology can
or cannot do, and what makes users perceive different constraints
or affordances based on the options obtainable by the material
aspects of the technology itself [22].
Theme 3: Accounting for Materialization
Leonardi explains that once the researcher understands
technology limitations and users’ intentions for its use and how
this impacts the affordances, it is important to expand the
analysis to comprehend the influence of technology on
organizing. This evolves around analyzing and realizing the
instances when specific affordances influence and transform
the actions, hierarchies, and relationships that constitute the
organizing process [22].
It is important to remember that not every technology will
clearly impact the organizing process, it is the creation and
enablement of specific affordances that helps materials and
materiality to materialize in a way that actually impacts
organizations and how work is being organized [22]. This idea
is emphasized in Leonardi’s example of how a group of
JMIR Mhealth Uhealth 2019 | vol. 7 | iss. 5 | e13555 | p.4https://mhealth.jmir.org/2019/5/e13555/
(page number not for citation purposes)
Jacob et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
technicians who were given a new Information Technology (IT)
system started by using it for its initially defined feature of
assigning jobs to others, and as they realized its affordances,
their use developed to use it for documenting completed jobs,
which further evolved to use this past documentation to define
who is the best technician to be assigned a new job based on
previous experiences. Only then did the new system start to
materialize as a crucial element in organizing and optimizing
work in that department [48].
Therefore, researchers need to understand how the current
patterns of organizing rely on the materiality of specific
technologies, why some organizing processes create a social
context in which technology can materialize in actions and
interactions’ flows, and how have the affordances enabled by
technology supported, changed, or transformed the way that
people work or interact in a specific organization [22].
Results
Accounting for the Materials: Utility and Limitations
Participants were first asked to name the features that they use
most in the app to better understand the technological artifacts
that they find most useful. They named the features in Table 2.
They were then asked to explain how the app helped them and
their patients on a daily basis to better understand ONCOassist’s
utility from their perspective; 3 key themes emerged as
visualized in Figure 1. The size of the circles reflects the
frequency of the themes; blue represents utility elements and
gray, limitations.
All participants mentioned that the app helps them to save time
and be more efficient in their daily work. The app also allows
a more seamless clinic experience for patients because it enables
clinicians to make critical decisions at the point of care, also
enhancing patient safety and quality of care. The compact
overview of numerous tools and the possibility to switch
between the Web application and the mobile app were also
highly valued. Sample participants’ quotes are reflected in
Multimedia Appendix 6.
To complete the picture, the participants were also asked about
any limitations they faced when using mHealth apps. And as
most participants did not recall many limitations in the
ONCOassist app, they were also asked to reflect on limitations
associated with other mHealth solutions they had experienced.
The limitations are visualized in Figure 2 and explained below.
Factors such as information incompleteness or incorrectness,
for example, outdated information, can be perceived as
limitations. Apps where the design is too cluttered and users
cannot find what they are looking for are usually abandoned.
This was not the case with ONCOassist, but some participants
mentioned it as the reason why they stopped using other apps.
Furthermore, interoperability and electronic medical record
(EMR) integration are the key system-related limitations that
most mHealth apps are currently facing. Shortage of resources
can be an issue, financing is a concern, especially in Europe, as
most hospitals are publicly funded. Again, this was not the case
with ONCOassist, which is free, but some participants
mentioned it as a general barrier with other paid mHealth
solutions. Sample participants’ quotes are also reflected in
Multimedia Appendix 6.
To have a deeper understanding of perceived limitations in the
current features, the participants were also asked to suggest new
features that they would like to add to the app. They requested
a link to guidelines, adding drug interactions, immunotherapy
toxicity, access to new research on different protocols and
regimes, adding a prostate-specific antigen (PSA) doubling
calculator, a feature for patient monitoring and management,
the possibility to use big data for predictive models, breast
cancer protocols, clinical trial matching, enabling a community
aspect for clinician discussions, local drug prices and
reimbursement information, geriatric tool improvement,
interpersonalization based on subspecialty, Systemic
Anti-Cancer Treatment (SACT) datasets, and product
characteristics.
Table 2. Most used features.
Sample quoteFeature
“I find it very easy for doses of toxicity… it’s very practical because it’s all in one” (P3)Toxicity criteria
“It’s really useful for when I have to calculate carboplatin dosage using the right formula. It allows me to do it all in
the app as opposed to the really, really long calculation that you normally have to make” (P4)
Calculators
“The main thing that I used the most was the AJCC because it has the super summarized staging” (P7)Staging tools
“I use ONCOassist for prognostic values in choosing adjuvant chemotherapies” (P6)Adjuvant tools
“It’s useful … especially with the new treatments. They’re evolving all the time” (P4)Product characteristics
“And the customer service specifically with ONCOassist is very good. I can directly ask, even if I’ve got any issues
and I need help with that” (P8)
Customer service
“And now the drug interaction checker, which is very, very, very important for us” (P6)Drug interaction
“A lot of hospitals, the way they are, for some reason the signal is never good. And therefore, that also has a bearing
on how these apps work” (P8)
Offline functionality
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Figure 1. Workflow Improvements and Disadvantages.
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Figure 2. Utility and Limitations.
In a follow-up interview, the ONCOassist team explained that
features such as the product characteristics and new research
on different protocols and regimes already exist in the app but
probably the participants who mentioned them were not aware
of it. Furthermore, the features drug interactions and PSA
doubling calculator were about to be launched at the time of
writing of this paper just in time to meet the participants’
requests. The patient monitoring and management feature is
also being piloted at the time of writing this paper.
The team explained that other requested features such as drug
prices and reimbursement information can be quite challenging
to implement because they can vary drastically from country to
country and they are subject to frequent change, which requires
a large team that is constantly working on updating this
information to guarantee it is correct.
Accounting for Materiality: Constraints and
Affordances
To understand affordances, it is important to first start by
understanding the intention for use. Therefore, the participants
were asked to explain why they decided to use the app in the
first place and what they intended to achieve with it.
Most participants decided to use the app because it could help
them save time and be more efficient as the information that
they need on a daily basis is aggregated reliably in one place;
it also increases efficiency by offering a standardized and
reliable tool. Recommendations from another oncologist, a
medical society, a conference, or even social media channels
such as LinkedIn motivated them to try the app; furthermore,
usefulness and the constant development and update make the
information on the app more accurate than other sources and
can improve the quality of care by aiding clinical decisions.
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For a more comprehensive analysis, it is also important to
consider the reasons for nonadoption; however, it was not
possible to recruit nonusers, presumably because they were not
interested in the topic. To address this gap, the participants were
asked about what they thought could be the reasons why other
colleagues might not adopt mHealth solutions. The main reasons
given were due to social and cultural factors such as attitude
toward technology, age, attitude toward change, previous
negative experiences, and perceptions of the use of a personal
device at work; furthermore, the nature of the role can also be
a factor; depending on how complex the role is, the need for
apps may differ. Also, there is a greater awareness of apps that
are advertised more and, accordingly, use is more widespread.
The interview questions evolved to address the participants’
more holistic views of the factors impacting the adoption of
mHealth from their perspective, going beyond ONCOassist to
have a general understanding of barriers and opportunities for
mHealth adoption. The main themes are reflected in Multimedia
Appendix 7 with sample participants’ quotes and a visual to
emphasize their frequency.
App operation and stability including factors such as app size,
offline functionality and reliability on connectivity, login issues,
and the type of device used may be perceived as constraints or
affordances to the use of such apps. Almost all participants
mentioned cost as a key factor that could hinder the adoption
of such apps, especially for younger clinicians. Most participants
mentioned ease of use as a decisive factor for the adoption.
Usefulness is also very important, that the app addresses a need
for clinicians to adopt it, purely informative solutions are not
perceived as value adding in the form of an app. Endorsement
and recommendations from people or institutions that they can
trust are an important factor for adoption. Reliability and
neutrality of the content, as well as things such as regulatory
approval, are decisive factors for the adoption.
Social and cultural factors that impact people’s attitudes toward
technology, such as digital savviness or perceptions of the use
of a personal device at work, can also play a considerable role
in the adoption. Work overload and workplace politics can also
play a role in the adoption, depending on what each clinician
is focusing on and prioritizing. Finally, the portability and
location flexibility of the app as a pocket solution is a significant
affordance for adoption.
Accounting for Materialization: Social and
Organizational Implications
The participants acknowledged several social and organizational
impacts of the app usage as visualized in Multimedia Appendix
8 to emphasize their frequency, along with participants’ sample
quotes.
The app helps users feel more empowered and autonomous.
The progress of Health Tech in general is fostering the creation
of new digital roles for clinicians and their involvement in digital
training and raising awareness about mHealth among their
colleagues. The decision to use one mHealth solution or the
other lies with the individual clinicians themselves and not
centralized through the administration.
Owing to the need for speed, location flexibility, and the limited
number of computers available at the workplace, clinicians
prefer to reach out to their personal mobile for quick access
rather than using the computers at work. Participants also noted
that new health technologies, including mHealth, are replacing
traditional tools in health care institutions. Also, if systematically
embraced by the organization, such an app could be used as a
tool for people evaluation and reward.
When asked about workflow improvements, the participants
brought up 3 key themes as visualized in Figure 1 and detailed
below. The size of the circles reflects the frequency of the
themes; the blue color represents workflow advantages, and the
gray color represents workflow disadvantages. Sample
participants’ quotes are reflected in Multimedia Appendix 9.
The app made their work easier, helped them be more efficient,
looked more professional, and meant less interruption. It also
sharpened their practice by giving them a backup and a safety
net. It offered them location flexibility by helping them
overcome computer shortage as well as decision making at the
point of care or in meetings; it can also be an alternative in
places where a computer is not allowed.
Participants also mentioned 2 workflow disadvantages that
should be considered, as shown in Figure 1.
There is still an interoperability issue, as the majority of mHealth
apps are not integrated into EMRs and therefore could easily
be dismissed in favor of bigger vendors who offer such an
integration. Cultural views on the usage of mobile phones at
work and the perception that it is wasting time can impact
mHealth users negatively in the workplace.
Future Vision and Clinicians’ Role in Adoption
Participants agreed that the future of mHealth is promising and
will have a considerable impact on health care. In total, 3 main
themes emerged in the discussion about their views of the future
of mHealth. They expect a rise in the adoption of mHealth
solutions, especially with the standardization of EMRs, and
such solutions can then be integrated or plugged into the system.
They also expect to be able to benefit from artificial intelligence
and all the big data that will result from the implementation of
EMRs more widely; such data can be fed through mHealth, for
example, to create predictive models and proactive treatment.
This could also enable a more patient-centric approach to health
care.
They all also agreed that clinicians would play a central role
not only in the adoption of mHealth solutions but also their
development as shown in Table 3.
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Table 3. Clinicians’ roles in the adoption of mHealth.
Sample quoteTheme
“By having CCIOs, clinical information officers, to get involved with the IT side
of service provision. So it’s not IT companies just serving up a ready-made
product, but they’re actually engaging clinicians at an earlier stage to make them
more useful” (P5); “And so we will have more and more, some doctors involved
in the development. Maybe if these companies will hire doctors” (P9); “I think
of having an experienced nurse that her daily job won’t be to see the patients but
rather to see the parameters on her computer … it’s like a control centre that will
take care of the patients” (P3)
New digital roles for clinicians, both in digital health start-ups and
in health care institutions
“Well, hopefully, we'll be engaged in the design of these processors, which we
are being, a little bit more than we used to be”, (P11); “I think the physicians who
know a lot can have good ideas and more things that can better these apps” (P5)
More involvement in the development and design, not only in the
early stages but also through the whole lifecycle of the app.
“So it’s organising forums that even that they can be discussed, and educating
other staff about them” (P12); “Education. Remove the fear. Stigmas about use
of mobile phones in workplace, in hospitals need to stop” (P4)
Education and awareness by acting as ambassadors, raising
awareness, and taking the lead for digital health education in health
care institutions
“And I don't think there is going to be any machine able to sit with a patient and
explain to them and look at them in the eye, all those things that robots don't do
but we as humans do” (P7)
With the efficiencies achieved with mHealth apps, clinicians will
be able to focus more on the human side and invest more time with
the patients themselves as opposed to spending all the time getting
the task done.
How Do These Insights Make Their Way Back to the
Design?
Given the interesting affordances and workflow impacts that
emerged from the insights, it was important to understand
whether the providers have processes that help them identify
these affordances, understand any limitation, and embed these
insights in the constant development of the tool. In a follow-up
interview with the team to better understand how they engage
their users, they explained that their key to success is to follow
Steve Bank’s advice by getting out of the building and talking
to their users [49]; one of the company’s founders explains,
“And part of our CE approval is that we're always engaging
with users, always asking how can we improve.”
Therefore, they established a process that enables them to
systematically engage with their users depending on how
engaged they are as visualized in Multimedia Appendix 10.
All active users receive weekly learning emails for the first few
weeks about various features on the app where they are also
asked to give feedback. Every user that exceeds 25 active
sessions automatically gets an email asking them to fill out a
survey; then after 50 sessions, they get another email prompting
them to leave app store feedback; they also get emails at various
stages throughout their life cycle, asking them what they think,
“Is there anything we need to improve?”
Inactive users, defined by the providers as every user that has
not used the app for 60 days, automatically get an email asking
them to fill out a survey to help the team better understand why
these users stopped using the app.
Engaged users, also known as power users, are the users that
give regular feedback, they are usually invited to a 30- to 60-min
interview during one of the major oncology conferences such
as the European Society for Medical Oncology to have a more
in-depth discussion with the team and give more detailed
feedback. The team explains the importance of these interviews
to them:
I think people are more likely to tell you like—when
you meet them in person, they’re going to tell you the
small little things that annoy them, more so when
they’re responding to surveys or emails. The slight
little things like, “I have to click here to go back here
to find this.” Those kind of things, which I think is
really useful.
The team started to identify users who were willing to be more
involved to be invited to become official advisors as part of the
extended team. One of the founders clarifies, “We need more
medical input, so we’re trying to kind of get this panel of
clinicians giving us input and paying them for that, in order to
kind of help us go to the next level of tools.” This effort has just
started, and the team is looking at how they can expand it.
After collecting the feedback, the team discusses together to
start screening the users’ input and decide on which features to
add accordingly; one of the founders explains:
We are lucky in that the majority of users request
similar tools and content, this makes our jobs easier.
I think as ONCOassist develops it’s obvious what is
missing, and most of our engaged users notice this
and point it out. It may be because certain tools and
content are becoming more relevant, because of new
products on the market. Sometimes we get feedback
that may be a little different, which is very useful as
well, but 60-70% of the time the requests are similar.
Other times we get requests for tools that are difficult
for us to build in the short to medium term. We take
note of this to see if trends emerge.
The team also ensured that there was a process to allow them
to inform the users when the feature they requested was
implemented, as they clarify, “We usually take note of the
emails, and then when it goes out, we let them know. And
there’s also—like we send them a short email, a personalised
message, saying, ‘Hey, just so you know, this is now live’. But
they’ll get a group email as well,” this helps the team build a
personal relationship with these engaged users.
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Some of the requests that they receive are also about existing
features, as they explain:
Other times—all of what our biggest problem at the
moment is around discovery. We have content in there
that people don’t know is available, so that’s
something we're working on as well. It’s like making
sure that people know that we have what they need
already… It can be an educational process.
The ongoing challenge that the company is facing, similar to
most mHealth start-ups, is monetization, as the team explains:
I feel like we’ve figured out the user interaction, and
getting that feedback, and building based on that
feedback. Now, for us, the big challenge is figuring
out how to kind of have a scalable model with
companies that results in us generating good revenues
and kind of having on-going relationships in helping
and showing improved outcomes.
Discussion
The results show that technology adoption in our case study is
influenced by factors that go beyond the technical and material
features of the app; there are other social and organizational
factors that play a crucial role in the adoption and success of
such new technologies as detailed below.
Understanding the Possibilities and Limitations of
Technological Artifacts
Overall, the participants found the app useful, but not all features
were seen as equally so; some were emphasized more than
others were and some more relevant to specific cases. Features
relevant to everyday tasks at the point of care such us toxicity
criteria, calculators, staging tools, and adjuvant tools topped the
list. Whereas other features, such as product characteristics,
were perceived as important in the case of new drugs because
clinicians may not be familiar with new medications and this
tool can allow them to quickly check drug-related information,
especially given that new drugs are continuously being
produced.
The main utility of the app is time saving and efficiency as it
helps busy clinicians in their daily work in different ways. From
one side, it serves as a memory aid as they cannot memorize all
the formulas and checking toxicity calculations, for example,
takes time, but with the app, they can get that in a couple of
seconds while on the go, this makes it faster and easier to extract
information. At the same time, the app helps them ensure higher
quality of care and patient safety by enabling them to make
critical decisions at the point of care, such as recalculating a
dose based on body weight fluctuation, contributing to a
seamless patient experience at the clinic or hospital. Clinicians
created further affordances by using it as a support tool in their
discussions with the patients to better explain to them why some
decisions were made (eg, why should they continue with
chemotherapy even after the tumor is out) extending the use of
the app from a clinician tool to a support tool in patient
discussions.
Even though the participants explained that there was nothing
in the app that they cannot find elsewhere (eg, medical websites
or paper-based calculators), it was the compact overview and
the presence of all relevant tools in a single app that is accessible
anywhere anytime that made it particularly useful for them.
Here, it is clear that the material features of the mobile app, its
portability, and accessibility played an important role in the way
it is being used by the users and why they perceived it as more
convenient and easier to use compared with possible alternatives.
However, the app is not without limitations; the lack of
information completeness or correctness is perceived as the
main limitation, for example, not all adjuvant tools are on the
app; hence, if clinicians need to use one that is missing from
the app, they will need to use a different tool to do so.
Design-related limitations such as clutter also made it difficult
for the users to find what they were looking for; this was not
the case for ONCOassist, but the participants mentioned that
they did face this issue with other medical apps. Hence,
reaffirming Kallinikos’ idea that the way a material feature is
shaped or arranged has an impact on the way it is actually used
[37]. The lack of EMR integration was also seen as a limitation,
such an integration would make it very easy to adjust
calculations and toxicity criteria to specific patient profiles and
electronic records, taking the app’s utility to a whole new level
of convenience and efficiency. This technological
interoperability hurdle confirms that often it is the software
rather than the feature themselves that can be limiting to some
technology uses [22]. Furthermore, there are also social and
organizational aspects such as shortage of time and financial
resources that can cause limitations to such solutions’ adoption.
When talking about limitations and features that they would
like to add to the app, it was interesting to see that some existing
features were on the requested list, showing that participants
were not always aware of everything that the app could do,
which underlined the crucial role of awareness and training.
Oudshoorn and Pinch emphasized this point when they explained
that the success and adoption of new technologies usually
depends on the users’ knowledge of its features and how to use
them, stating that “It has long been recognized that the most
sophisticated and complex computer hardware and software
will come to naught if users don’t know how to use them” [50].
Understanding Constraints and Affordances as Defined
by the Users
When exploring the intention of use and the initial motives that
encouraged initial use of the app, participants highlighted several
features of the app and what it enabled them to achieve, that is,
saving them time, increasing work efficiency, and improving
quality of patient care. As Gibson proposes, users might refrain
from interacting with an object or in this case a technological
solution, without learning what it is good for [42]. However,
participants also mentioned some aspects related to what
technology in general allows, such as the constant development
and update of digital sources, which makes them more accurate
than media—such as medical books or paper-based tools.
However, social aspects, such as endorsement, also impacted
the intention of use, which is a reason for adoption given by
nearly all participants. Hence, clinicians mostly trust tools that
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are endorsed by other clinicians or reliable medical associates
they know, showing how social and material aspects start to
become entangled, while the decision for adoption does not
only rely solely on the tool’s features and capabilities but also
on social aspects such as trusted endorsement. This implies that
without social aspects such as endorsement some exceptional
mHealth solutions might not get used.
Social and cultural factors are perceived as the main source of
constraints when it comes to mHealth adoption; general attitude
toward technology and change, age, previous negative
experiences, and perceptions of the use of a personal device at
work can be decisive factors in the nonadoption of mHealth
according to participants. For instance, an important example
of entanglement of the social and the material is when the use
of the smartphone at work is routinely perceived as a
nonprofessional activity. Even though professional apps that
can run on smartphones are no longer a novelty, the stigma
related to the use of personal devices at work persists. Users
being concerned with negative perceptions resulting from
cultural views of smartphone use at work validates previous
scholars’ argument that “culture tells us what something
affords,” implying that constraints and affordances are the joint
result of the entanglement between the material aspects of
technology and cultural practices forming users’ perceptions
[22,51].
A further look into the participants’ views of what elements
would afford or constrain mHealth helps us understand
materiality at the intersection between social and material
aspects as Faraj and Azad and Majchrzak et al explain [40,41].
The material aspects mentioned by clinicians mostly evolved
around app stability and operation, cost, ease of use, usefulness,
and portability; these findings agree with previous research that
also reported similar factors [3,52].
However, these aspects intertwined with other important social
aspects namely recommendations from people or institutions
they can trust, reliability and neutrality of the content (the
content provider must be neutral to be trusted, whereas examples
given highlighted concerns of bias where content was provided
by Pharma companies), social and cultural factors impacting
people’s attitudes toward technology, and some organizational
factors such as workload and internal politics. These findings
complement previous research that shed light on nontechnical
factors that play a crucial role in mHealth adoption [53-56].
It’s also worth noting, however, how the material properties of
different technologies can also afford different use cases
depending on the context they are being used in [22]; this was
clear with participants’ experiences around how they switch
between the mobile app and the Web app on the desktop when
they are using ONCOassist. Several examples showed that the
mobile app’s portability, accessibility, and compact overview
are the key added values of the solution; however, in specific
social contexts, that is, if the clinician is showing a graph to the
patients using the app they might prefer to use the Web
application to avoid a personal message showing on the phone
being seen by the patient, which, in turn, might appear as
unprofessional. This highlights the importance of both mobile
apps and Web applications as their use can differ from one social
context to another.
Understanding How Technology Materialized in the
Organizing Process
Various social and organizational impacts of the app usage were
mentioned, namely people empowerment, as the app helps users
be more autonomous and gives them more power through
knowledge and education; it also empowers young doctors that
find themselves in an environment that does not encourage
questions as they can find answers to any queries via the app
without having to ask a more senior colleague. Furthermore, at
this early stage of adoption, the decision making is still
individualized, meaning that the decision to use one mHealth
solution or another lies with the individual clinicians themselves;
however, this may change as the rise of the adoption of such
solutions is also driving the creation of new roles for clinicians
evolving around digital solutions. We now start to see clinical
information officers in some hospitals and clinics to deal not
only with the medical aspects but also the IT side of such
services including topics such as interoperability and software
integration, which could lead to more centralized decision
making in the future.
Clinicians also prefer to use their personal devices rather than
the work devices due to the need for speed, location flexibility,
and the limited number of computers available at the workplace.
In addition, these apps are rapidly replacing some traditional
tools such as textbooks, paper-based calculators, and websites.
Another example that can have clear organizational implications
is the use of the app for people evaluation and rewards through,
for example, streamlining the calculations and SACT datasets
and attaching them to Commissioning for Quality and
Innovation, based on which staff members get monetary rewards.
However, this is only feasible if it is systematically embraced
by the organization and not decided on an individual basis. This
reinforces the argument that the impact of the materials and
materiality on the organizing process can only be seen if
something enables their materialization [22]; in our example,
this would not happen unless the management enforces the use
of the app for people evaluation and rewards.
As for workflow advantages, the app enhanced users’ efficiency
and performance by making their work easier, quicker, more
professional, and with fewer interruptions. It also led to a
sharpened practice because it provided a backup solution and
a safety net to double check drug dosages and calculations then
adjust in case of fluctuations in patient’s weight, for example.
The personal phone usage also enabled location flexibility; by
helping them overcome computer shortages or instant decision
making at the point of care or in meetings, it can also provide
a solution in places where traditional devices are not permitted
such as the clinical room where computers are not allowed
because of infection control.
Nevertheless, interoperability and lack of integration with EMRs
are seen as key workflow disadvantages because the app as it
stands today cannot be directly linked to a specific patient health
record, meaning that clinicians have to enter the individual
patient values manually for each calculation. Some participants
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suggest that apps that do not offer EMR integration could easily
be dismissed in favor of bigger vendors who offer such an
integration. On the contrary, cultural aspects such as assumptions
made regarding mobile phone usage in the workplace and the
perception that it is a waste of time could impact mHealth users
negatively in the workplace unless tackled and awareness is
raised.
These insights complement the existing literature that pinpointed
the importance of organizational and workflow factors that can
considerably hinder mHealth adoption if not addressed properly
[6,54,57]
Accounting for User Engagement: Affordances
Enablement
The 3 steps in Leonardi’s methodological guidelines smoothly
lead us into understanding the materials, followed by materiality,
then materialization, and how the materiality impacts the
organizing process. What it does not address though is how can
the affordances be enabled through user engagement; in other
words, how is user feedback considered and how does this
feedback make its way into the design process. It is important
to find a way to identify mechanisms that would enable the
designers to understand and maximize the potential of the
affordances created by the users.
ONCOassist offers a best practice example of embedding the
users in the development process and how it made for a constant
interaction between the social and the material, allowing the
material to develop in a way that best serves both organizational
and social practices. They explained how they capture feedback
from every user category depending on their level of engagement
and that they keep adding new features based on this feedback.
They also recently established an advisory board that includes
some of the apps’ power users. This enables them to always be
on top of newly emerging medical needs and stay relevant in a
world that is constantly changing.
From their side, clinicians showed clear interest in being a part
of the development process and foresee a rise in digital roles
for clinicians, both in digital health start-ups and in health care
institutions. This would entail more involvement in the
development and design of such solutions, not only in the early
stages but also through the whole lifecycle of the app, and they
would act as ambassadors raising awareness and taking the lead
for digital health education in health care institutions. Some
clinicians are clear advocates of such solutions because they
believe that it would help them focus more on the human side
through the efficiencies that they create.
This paper proposes the addition of a fourth step to Leonardi’s
guidelines to account for user engagement as visualized in
Figure 3 [22], by identifying existing feedback loops,
understanding which user-suggested features and affordances
are selected for further development, how they are selected and
based on which criteria, and who the decision maker is. These
questions would help to capture any processes that activate the
role of the users and the implementation of affordances that
might arise.
Including the users in the constant development and testing of
innovative tools is not without challenges, especially considering
the very competitive environment that mHealth start-ups are
operating in; hence, they are protective of their ideas, which
results in most of the design and testing being done inside the
company without involving anyone external [58]. This, however,
needs to change to enable the user-created affordances to make
their way to the design and to ensure that these new tools will
stay relevant to the users in a world that changes continuously.
A balance between user engagement and confidentiality can be
achieved through advisory contracts, nondisclosure agreements,
or the like.
Practical and Theoretical Implications
This case demonstrates the affordances and constraints of
mHealth technology at the workplace, their implications for the
organization of work, and clinicians’ role in their constant
development and adoption. The research findings confirmed
that factors such as app operation and stability, ease of use,
usefulness, cost, and portability play a major role in the
adoption. However, other social factors such as endorsement,
neutrality of the content, attitude toward technology, workload,
and internal politics are also perceived as key determinants of
adoption.
Figure 3. Accounting for User Engagement.
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Several organizational implications also emerged, suggesting
the need for some actions such as fostering a work culture that
embraces new technologies and the creation of new digital roles
for clinicians both on the hospitals or clinics and on the
development sides but also more collaboration between health
care organizations and digital health providers to enable EMR
integration and solve any interoperability issues.
From a theoretical perspective, this study suggests the addition
of a fourth step to Leonardi’s methodological guidance to
account for user engagement; embedding the users in the
continuous design and development processes ensures the
understanding of user-specific affordances that can then be made
more obvious to other users and increase the potential of such
tools to go beyond their technological features and have a higher
impact on workflow and the organizing process.
Limitations and Recommendations for Future
Research
This case study is limited to a specific mHealth solution and a
specific geography during a specific timeframe, and therefore
its findings may not be generalizable to other contexts where,
for example, the health care system and its regulations could
be considerably different. Furthermore, the sample size is
relatively small and excluded nonusers because their recruitment
proved to be very challenging. Moreover, given the constantly
evolving nature of mHealth, the context of the research might
change very quickly necessitating new research to update the
findings.
To address some of these limitations, future research should
cover other mHealth solutions in other geographies, timeframes,
and contexts. It would also be very relevant to include some
nonusers to the participants mix to cover their views as well.
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